The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I don't know what chart you use dumbass but Tradingview gives you 1/5 day, 1/3/6 months. Even Google finance is 1/5 day 3/6 month. Maybe you don't like to look further back than a month because you see what a mug you were buying at 79p. You epitomise the ********s on here that throw around insults when anyone posts anything cautious about a Co their invested in.
@chasethedragon
The rampers are the worst thing about LSE. Ive noticed that if people question a sp or the company credentials on a BB they get rounded on you. It's so obvious rampers are worried that their pump won't work or that their holding drops in value if people don't buy into their hype. As you say, very rarely do you get considered DD, they mostly resort to insults. Scourge of LSE.
Sorry to hear your story Gareth. It might be worth a listen to @eddiedavis2707 pinned podcast on Twitter. 19 minutes in is when he starts to talk about his investing journey and how he lost money listening to rampers on LSE and Twitter. I'm not long on LSE and everywhere I look there are people talking up a stock like it's the next Tesla and pulling multiples out the air. It's easy to get sucked in. As people repeatedly say DYOR and only rely on your own evaluation. Averaging down needs careful consideration. It works if the sp goes up obviously otherwise you throw good money after bad. It's extremely difficult to place a valuation on Cellular at this stage and it's anybody's guess where the sp goes from here. Don't listen to people saying it's going to up or that it's going back to 5p because they don't know.
@Jman2.
Was it AJBell that did not give you your IPO shares until today? On Friday I'm sure someone with AJBell said their shares were available at opening.
The Ava6000 sounds very exciting but just been reading that an MIT group Wong et al 2019 found only 3.4% of oncology phase one trials succeeded. That sounds to me like an awful lot of what would have been promising products not making it through. Avacta are using a proven drug in Doxorubicin so that might increase the chances of success?
This was great play if you got into the IPO to take the profit as many have but I'm not seeing the risk/ reward at this price. There are already lots of CBD creams etc out there and it's going to be a massively crowded marketplace by the time Cellular release products. It's possible they might do well but it's a very high risk investment imo. If you're in high it might be worth holding but this could also slide back further who knows, it really is just a punt stock. Beckham Holdings have not done well lately so I wouldn't rely on his name to get a consumer to buy the product, if indeed he does ever activily promote it.
Thank you AgentB. That is a very helpful orientation for me. Yes it is exciting. Definitely the type of company I'd like to see do well and feel good investing in. Going to do as much reading as I can and I expect I'll be buying in to this.
Ive just come across Avacta and watched AS on Vox. Impressive individual and the Precision product sounds a brilliant treatment with promise sp wise. Late to the party but thinking of investing. With respect to the lateral flow test, does anyone know how Avatca compares to ODX and the Porta Down test? Is the best likely be to win out? Just started my reading but it would be good to have a few pointers. Thanks.
I suspect a sell off Monday from people who saw Beckham involved, bought for the predicted hike in price with the hype and take profit. I've no argument against people seeing an opportunity. I missed the IPO but not touching this at current price. Long term it might have value if the products are well received but that's a big unknown and I'm not convinced Beckham will promote this so I don't know if his name will help. Beckham Brand went from 12m profit to 1.5 loss 2017-18 so I'm not entirely bought into his influence here but not ruling it out either.
I read the global CBD skin care market is expected to reach between USD 1.7 -3.5 billion by 2025 but also that 6 firms are active already. I expect this to become a crowded marketplace but it sounds like there will be some winners.
This is very early days for Cellular. I can't see the argument for a significant valuation other than a bet if it pays off. It might be a good bet, but sure feels like a risky one. If I invest it would only be a small sum just as a punt but I don't think I'd buy above 10 just now and hype might keep it above that.
That's an ironic response on the day that BTC lost more $ value than any other day in its history. What if BTC had crashed below $40k and then stabilized, while my stop loss triggers at $50k and I buy back in at $40k? Not everyone is going to want to adopt your hypothesis. Seems you rate posts according to whether they agree with your philosophy.
I tried out the Mode App but couldn't find a stop loss option. I wouldn't hold bitcoin in any App without setting a stop loss. I think no stop loss option is a major disadvantage that will put people off adopting the Mode App. Some people might use an alert but I wouldn't woken up at 3am by an alert and there will be times my phone isn't on me.